BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17223196)

  • 1. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
    Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
    Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma impairs chemokine-mediated dendritic cell migration in vitro.
    Walker SR; Ogagan PD; DeAlmeida D; Aboka AM; Barksdale EM
    J Pediatr Surg; 2006 Jan; 41(1):260-5. PubMed ID: 16410144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes.
    Dai YQ; Jin DZ; Zhu XZ; Lei DL
    Neurosci Res; 2006 Jun; 55(2):154-60. PubMed ID: 16600409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.
    Yanagihara S; Komura E; Nagafune J; Watarai H; Yamaguchi Y
    J Immunol; 1998 Sep; 161(6):3096-102. PubMed ID: 9743376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-κB and MAP kinases in lipopolysaccharide-treated PC12 cells.
    Geng Y; Fang M; Wang J; Yu H; Hu Z; Yew DT; Chen W
    Phytother Res; 2012 Mar; 26(3):337-43. PubMed ID: 21717513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation.
    Liu Q; Chen T; Chen G; Li N; Wang J; Ma P; Cao X
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1122-30. PubMed ID: 16713992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation.
    Wu WL; Ho LJ; Chang DM; Chen CH; Lai JH
    Eur J Immunol; 2009 Dec; 39(12):3413-22. PubMed ID: 19862774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells.
    Weng Y; Sun J; Wu Q; Pan J
    J Neuroimmunol; 2007 Jan; 182(1-2):48-54. PubMed ID: 17081624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation.
    Liu Q; Chen T; Chen H; Zhang M; Li N; Lu Z; Ma P; Cao X
    Biochem Biophys Res Commun; 2004 Jul; 319(3):980-6. PubMed ID: 15184078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
    Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C1q chemoattracts human dendritic cells and enhances migration of mature dendritic cells to CCL19 via activation of AKT and MAPK pathways.
    Liu S; Wu J; Zhang T; Qian B; Wu P; Li L; Yu Y; Cao X
    Mol Immunol; 2008 Dec; 46(2):242-9. PubMed ID: 18838169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
    Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
    Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide affects the differentiation, maturation and function of human dendritic cells.
    Zhu KJ; Shen QY; Cheng H; Mao XH; Lao LM; Hao GL
    Int Immunopharmacol; 2005 Aug; 5(9):1415-26. PubMed ID: 15953568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
    Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
    Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
    J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs.
    Jeannin P; Magistrelli G; Herbault N; Goetsch L; Godefroy S; Charbonnier P; Gonzalez A; Delneste Y
    Eur J Immunol; 2003 Feb; 33(2):326-33. PubMed ID: 12548563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile.
    Neves BM; Cruz MT; Francisco V; Garcia-Rodriguez C; Silvestre R; Cordeiro-da-Silva A; Dinis AM; Batista MT; Duarte CB; Lopes MC
    Mol Immunol; 2009 Aug; 46(13):2481-92. PubMed ID: 19520433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression.
    Hegde S; Pahne J; Smola-Hess S
    FASEB J; 2004 Sep; 18(12):1439-41. PubMed ID: 15247147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation.
    Liu Y; Chen Y; Liu FQ; Lamb JR; Tam PK
    Transpl Int; 2008 May; 21(5):483-94. PubMed ID: 18266776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration.
    Humrich JY; Humrich JH; Averbeck M; Thumann P; Termeer C; Kämpgen E; Schuler G; Jenne L
    Immunology; 2006 Feb; 117(2):238-47. PubMed ID: 16423060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.